Healthcare Sales & Marketing Network: FDA : Medical Device and Pharmaceutical News

Healthcare News Roundup: FDA

HSMN NewsFeed - 14 Mar 2022
Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Mar 2022
Shoulder Innovations Announces FDA Clearance of New InSet(TM) Stemless Humeral Implant
Devices Orthopaedic FDA

HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
Devices Interventional FDA

HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Mar 2022
RegeneRx Provides Regulatory Update Regarding RGN-259
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 2 Mar 2022
Valencia Technologies Announces FDA Approval of eCoin(R) Therapy to Treat Urinary Urge Incontinence
Devices Urology FDA

HSMN NewsFeed - 21 Feb 2022
Abbott's CardioMEMS(TM) HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 16 Feb 2022
Bonalive(R) Biomaterials Ltd. Granted FDA Breakthrough Device Designation for a Bone Graft Substitute that Potentially Protects Against Microbial Colonization
Devices Orthopaedic FDA

HSMN NewsFeed - 15 Feb 2022
Cardiosense Receives FDA Breakthrough Device Designation for Algorithm to Identify Patients at Risk of Decompensated Heart Failure
Devices Cardiology FDA

HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch

HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA

HSMN NewsFeed - 8 Feb 2022
CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt(R) System for Patients with Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery FDA

HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
Devices Interventional Cardiology FDA

HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
Biopharmaceuticals Diagnostics Oncology FDA

HSMN NewsFeed - 7 Feb 2022
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Devices Gastroenterology Oncology FDA

HSMN NewsFeed - 1 Feb 2022
FDA Clears World's First Credit-Card-Sized Personal ECG
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
Devices Dermatology FDA

HSMN NewsFeed - 25 Jan 2022
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients
Regenerative Medicine Ophthalmology FDA

Older FDA stories Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!